Prostatic Artery Embolization Market is Growing as a Minimally Invasive Treatment

 

Prostatic Artery Embolization Market

Prostatic artery embolization (PAE) involves blocking the tiny blood vessels that supply the prostate gland by injecting tiny particles into the arteries. It is a minimally invasive procedure that offers benefits over traditional treatments for benign prostatic hyperplasia (BPH) such as better efficacy, shorter recovery time and no major complications. PAE enables targeted therapy by blocking the arteries that supply blood to the enlarged prostate tissue, causing it to recede in size and relieving urinary symptoms. Several studies have demonstrated its effectiveness in alleviating BPH symptoms including urinary flow rate improvement and decreased prostate size of 30-40% within 3-6 months after the procedure.

The Global Prostatic Artery Embolization Market is estimated to be valued at US$ 270.72 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Prostatic Artery Embolization market are Ingersoll-Rand plc (Nexia), Vivint, Inc., Protection One Alarm Monitoring, Inc., The ADT Corporation, Telus Communications, Frontpoint Security Solutions, AT&T Inc., Johnson Controls, Inc., Comcast Corporation, Charter Communications (TWC), and CenturyLink, Inc. The growing prevalence of BPH in aging males is generating increased demand for minimally invasive treatment options like PAE. Awareness about PAE's benefits over TURP and fewer complications is further boosting adoption. Leading players are investing in extensive research to prove its long term effectiveness and expand indications in order to penetrate developing regions and achieve global expansion.

Market key trends

One of the major trends in the Prostatic Artery Embolization Market Demand is the development of new embolic agents. Researchers are developing more advanced embolic agents like drug eluting beads that could enable targeted drug delivery to the prostate and help improve outcomes. These next generation agents aim to offer longer duration of efficacy by controlled release of drugs like doxorubicin directly at the treatment site. Their widespread adoption could significantly boost the market by enhancing PAE's effectiveness as a minimally invasive option for BPH treatment over the coming years.


Porter’s Analysis
Threat of new entrants: High capital requirements for building infrastructure and research & development poses significant entry barriers for new players.

Bargaining power of buyers: Relatively low as the demand for prostatic artery embolization comes from healthcare providers and individual patients have limited influence in the highly regulated healthcare market.

Bargaining power of suppliers: Moderate as the requirement of materials, devices and technologies sourced externally are specialized limiting absolute supplier control.

Threat of new substitutes: Low as prostatic artery embolization has demonstrated advantages over alternatives treatments like TURP for BPH with minimal risk and invasiveness.

Competitive rivalry: Intense as major Prostatic Artery Embolization Market Analysis compete based on procedural efficiencies, product innovations and marketing campaigns to physicians and patients.

Geographical Regions
Currently, the North American region holds the major share of the global prostatic artery embolization market in terms of value majorly due to high BPH prevalence, growing awareness about minimally invasive treatments and favorable reimbursement structure in countries like the US.

The Asia Pacific region is anticipated to witness the fastest growth during the forecast period from 2024 to 2031. Factors such as expansion of healthcare infrastructure, rising medical tourism, growing focus of major players on developing countries through collaborations and acquisitions will support the market growth in Asia Pacific. In particular, China and India are expected to emerge as highly lucrative markets.

Get more insights on Prostatic Artery Embolization Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

Comments

Post a Comment

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Image
   Windsurf Foil Board Market In the exhilarating world of water sports, the Windsurf Foil Board Market emerges as a key player, offering enthusiasts innovative equipment to enhance their riding experience. As this niche market continues to gain traction among windsurfing aficionados worldwide, it undergoes significant shifts influenced by various drivers, challenges, and geographical nuances. The Windsurf Foil Board Market size was valued at  US$ 167.4 Mn in 2024  and is expected to reach  US$ 268.6 Mn by 2031 , growing at a compound annual growth rate  (CAGR) of 7% from 2024 to 2031 Key Takeaways A prominent trend in the Windsurf Foil Board Market Demand is the increasing adoption of foil technology. Foil boards, equipped with hydrofoils beneath the waterline, enable riders to glide effortlessly above the water's surface, providing a thrilling and dynamic experience. This technological innovation has revolutionized the windsurfing landscape, attrac...
Read more

Idiopathic Hypersomnia Treatment Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of Idiopathic Hypersomnia

Image
  Idiopathic Hypersomnia Treatment Market Idiopathic hypersomnia is a neurological sleep disorder characterized by excessive daytime sleepiness and long periods of sleep that does not improve even after long sleep. The treatment of idiopathic hypersomnia is done through medication and behavioral therapies. Medications like psychostimulants, serotonin modulators, wakefulness promoting agents are used to treat the condition and increase wakefulness. The increasing prevalence of idiopathic hypersomnia due to genetic and environmental factors is expected to drive the growth of the idiopathic hypersomnia treatment market. The Global Idiopathic Hypersomnia Treatment Market is estimated to be valued at US$ 389.86 Mn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the Idiopathic Hypersomnia Treatment Market are Esaote SPA, Epica Animal Health, IDEXX Laboratories, Carestream Health, IMV Imaging, Fujifilm Hold...
Read more

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Image
  Niemann-Pick Disease Drug Type C Treatment Market Key Takeaways The Niemann-Pick Disease Drug Type C Treatment Market is witnessing significant growth, driven by advancements in medical research and a deeper understanding of the disease pathology. Niemann-Pick Disease Type C (NPC) is a rare genetic disorder characterized by the accumulation of cholesterol and other lipids within cells, leading to progressive neurological and visceral symptoms. With an increasing focus on rare diseases and orphan drug development, the market for NPC treatment is expanding rapidly, offering hope to patients and caregivers. Key players in the pharmaceutical industry are actively investing in research and development to bring novel therapies to market, underscoring the potential for transformative interventions in NPC management. Global Niemann-Pick Disease Drug Type C Treatment Market is estimated to be valued at  US$ 45.40  million  in 2024, and is expected to exhibit a  CAG...
Read more